Scientists test tetanus bacteria as a weapon to target pancreatic tumors - STAT

In new research on mice, scientists report that a treatment harnessing Listeria and tetanus bacteria prolonged survival from pancreatic cancer. The biotech company Loki Therapeutics has licensed the patent for the approach.

Pancreatic cancer has proved one of the most deadly forms of the disease, and the most difficult to crack. It shrugs off immunotherapy drugs and resists chemotherapy, and only about 10% of patients l… [+633 chars]

full article...